Sabby Management’s Bristol-Myers Squibb BMY Stock Holding History

Sabby Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-281	Closed	-$1.78M	–	152
2018 Q1	$1.78M	Sell	281 -34,401	-99%	-$2.21M	0.21%	42
2017 Q4	$213M	Buy	34,682 +1,613	+5%	+$101K	19.36%	1
2017 Q3	$211M	Sell	33,069 -227	-0.7%	-$13.3K	13.77%	2
2017 Q2	$186M	Buy	33,296 +14,823	+80%	+$807K	12.14%	2
2017 Q1	$100M	Buy	18,473 +9,995	+118%	+$548K	5.42%	5
2016 Q4	$49.5M	Buy	8,478 +5,009	+144%	+$274K	2.88%	10
2016 Q3	$18.7M	Buy	+3,469	New	+$223K	0.7%	29
2015 Q1	–	Sell	-2,359	Closed	-$13.9K	–	299
2014 Q4	$13.9K	Hold	2,359	–	–	0.44%	29
2014 Q3	$12.1K	Buy	2,359 +465	+25%	+$23.2K	0.46%	36
2014 Q2	$9.19M	Buy	1,894 +1,722	+1,001%	+$84.9K	0.39%	39
2014 Q1	$894K	Sell	172 -60	-26%	-$3.19K	0.05%	143
2013 Q4	$1.23M	Buy	232 +172	+287%	+$8.76K	0.08%	105
2013 Q3	$278K	Buy	+60	New	+$2.63K	0.02%	176

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management's BMY Position: Q2 2018 in Review

Sabby Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 23,312 shares — an estimated $1.47M sold.

Sabby Management first reported a position in BMY in Q2 2014 and held it in 8 quarters. The position peaked at $111M in Q2 2017. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Sabby Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Sabby Management sold 23,312 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.47M.
Sabby Management first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 8 quarters.
Sabby Management's Bristol-Myers Squibb position peaked at $111M in Q2 2017.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.